Devices, systems, and methods for adjustably tensioning artificial chordae between leaflets and papillary muscles or heart walls
By using an adjustable artificial chordae tendineae system between the heart valve leaflets and papillary muscles or the heart wall, and by adjusting the tension of the chordae tendineae by controlling the locking portion with an actuator, the invasiveness and persistence issues of existing mitral valve disease treatments are resolved, achieving effective repair of heart valve regurgitation and optimization of blood flow.
Patent Information
- Application Number
- CN202080042479.9
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Priority Date
- 2019-07-12
- Filing Date
- 2020-07-02
- Publication Date
- 2026-03-20
- Estimated Expiration
- 2040-10-11
AI Technical Summary
Existing technologies for treating mitral valve disease involve complex invasive surgeries that cannot provide a lasting solution to regurgitation, nor can they effectively repair and/or replace damaged chordae tendineae.
An artificial chordae tendineae system is used, which can be connected between the clamp and the anchor. The locking part is controlled by the actuator to adjust the tension of the chordae tendineae. The anchor is engaged with the leaflets of the heart valve and the papillary muscles or the heart wall. The locking part prevents the movement of the chordae tendineae in a specific direction, thus achieving adjustable tension of the chordae tendineae.
It enables visualized adjustment and repair of valvular regurgitation, reduces blood reflux, and provides a more lasting and effective treatment effect.